193 related articles for article (PubMed ID: 7093104)
1. The acute and chronic hypotensive effect of labetalol and the relationship with pretreatment plasma noradrenaline levels.
Agabiti-Rosei E; Alicandri CL; Beschi M; Castellano M; Fariello R; Montini E; Muiesan ML; Romanelli G; Muiesan G
Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):87S-92S. PubMed ID: 7093104
[TBL] [Abstract][Full Text] [Related]
2. Acute haemodynamic effects of labetalol and its subsequent use of an oral hypotensive agent.
Joekes AM; Thompson FD
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):789-93. PubMed ID: 990156
[TBL] [Abstract][Full Text] [Related]
3. Haemodynamic effects of long-term oral labetalol.
Edwards RC; Raftery EB
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):733-6. PubMed ID: 791328
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.
Lund-Johansen P
Drugs; 1984; 28 Suppl 2():35-50. PubMed ID: 6151890
[TBL] [Abstract][Full Text] [Related]
5. Circulatory effects of noradrenaline and adrenaline before and after labetalol.
Richards DA; Prichard BN; Hernández R
Br J Clin Pharmacol; 1979 Apr; 7(4):371-8. PubMed ID: 444356
[No Abstract] [Full Text] [Related]
6. Catecholamines and haemodynamics in fixed essential hypertension.
Agabiti-Rosei E; Alicandri C; Fariello R; Muiesan G
Clin Sci (Lond); 1979 Dec; 57 Suppl 5():193s-196s. PubMed ID: 540429
[TBL] [Abstract][Full Text] [Related]
7. Sympathetic nervous activity and the pressor effect of noradrenaline under chronic alpha-beta-adrenoceptor blockade with labetalol in hypertension.
Zschiedrich H; Neurohr W; Lüth JB; Philipp T; Distler A
Klin Wochenschr; 1983 Jul; 61(13):661-7. PubMed ID: 6310204
[TBL] [Abstract][Full Text] [Related]
8. Acute hemodynamic effects of labetalol in severe hypertension.
Omvik P; Lund-Johansen P
J Cardiovasc Pharmacol; 1982; 4(6):915-20. PubMed ID: 6185782
[TBL] [Abstract][Full Text] [Related]
9. Haemodynamic effects of combined alpha- and beta-adrenoreceptor blockade after intravenous labetalol in hypertensive patients at rest and during exercise.
Koch G
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):725-8. PubMed ID: 10950
[TBL] [Abstract][Full Text] [Related]
10. Effect of labetalol on plasma noradrenaline and adrenaline in hypertensive man.
Christensen NJ; Trap-Jensen J; Svendsen TL; Rasmussen S; Nielsen PE
Eur J Clin Pharmacol; 1978 Dec; 14(4):227-30. PubMed ID: 365539
[TBL] [Abstract][Full Text] [Related]
11. Intravenous dilevalol. Effects of the R-R optical isomer of labetalol in patients with severe hypertension.
Wallin JD; Cook ME; Clifton GG; Blasucci DJ; Poland M
Arch Intern Med; 1988 Mar; 148(3):534-8. PubMed ID: 3277568
[TBL] [Abstract][Full Text] [Related]
12. Effect of labetalol on plasma catecholamines at rest and during increased sympathetic activity.
Carlsen JE; Trap-Jensen J; Svendsen TL; Nielsen PE; Rasmussen S; Christensen NJ
Postgrad Med J; 1980; 56 Suppl 2():43-8. PubMed ID: 7433342
[TBL] [Abstract][Full Text] [Related]
13. Intravenous labetalol for the treatment of hypertension after carotid endarterectomy.
Goldberg ME; Seltzer JL; Azad SS; Smullens SN; Marr AT; Larijani GE
J Cardiothorac Anesth; 1989 Aug; 3(4):411-7. PubMed ID: 2577702
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic and humoral effects of intravenous dilevalol in patients with moderate hypertension.
Grossman E; Messerli FH; Oren S; MacPhee AA
Am J Cardiol; 1989 Jun; 63(19):34I-37I. PubMed ID: 2524958
[TBL] [Abstract][Full Text] [Related]
15. Blood pressure reduction by incremental infusion of labetalol in patients with severe hypertension.
Cummings AM; Brown JJ; Fraser R; Lever AF; Morton JJ; Richards DA; Robertson JI
Br J Clin Pharmacol; 1979 Oct; 8(4):359-64. PubMed ID: 508511
[TBL] [Abstract][Full Text] [Related]
16. Systemic, pulmonary, and coronary hemodynamic effects of labetalol in hypertensive subjects.
Mehta J; Feldman RL; Marx JD; Kelly GA
Am J Med; 1983 Oct; 75(4A):32-9. PubMed ID: 6638039
[TBL] [Abstract][Full Text] [Related]
17. Sequential haemodynamic effects of labetalol at rest and during exercise in essential hypertension.
Svendsen TL; Rasmussen S; Hartling OJ; Nielsen PE; Trap-Jensen J
Postgrad Med J; 1980; 56 Suppl 2():21-6. PubMed ID: 7433338
[TBL] [Abstract][Full Text] [Related]
18. Effects of combined alpha- and beta-blockade by labetalol in patients with coronary artery disease.
Condorelli M; Brevetti G; Chiariello M; Miceli D; Lavecchia G; Paudice G; Verrienti S
Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):101S-110S. PubMed ID: 7093092
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic and coronary effects of intravenous labetalol in coronary artery disease.
Gagnon RM; Morissette M; Présant S; Savard D; Lemire J
Am J Cardiol; 1982 Apr; 49(5):1267-9. PubMed ID: 7064851
[TBL] [Abstract][Full Text] [Related]
20. Treatment of severe hypertension with intravenous labetalol.
Papademetriou V; Notargiacomo AV; Khatri IM; Freis ED
Clin Pharmacol Ther; 1982 Oct; 32(4):431-5. PubMed ID: 7116758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
